Amide inhibitors of microsomal triglyceride transfer protein
申请人:——
公开号:US20020156281A1
公开(公告)日:2002-10-24
The present invention provides compounds having the Formula I
1
The present invention also provides pharmaceutical compositions comprising a compound of Formula I and methods of treatment of atherosclerosis, obesity, restenosis, coronary heart disease, hyperlipoproteinemia, hypercholesterolemia, and hypertriglyceridemia.
A copper-catalyzedaerobic 3-hydroxyisoindolinone synthesis was developed via the benzylic double C(sp3)–H functionalization of 2-alkylbenzamides. In this reaction, molecular oxygen was used as both an oxidant for C(sp3)–H functionalization and an oxygen source. Our method can be extended to diverse benzylic C(sp3)–H bonds and shows excellent functional group tolerance.